- Home
- OABI vs CYBN Comparison
OABI vs CYBN Comparison
Compare OABI & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- CYBN
- Stock Information
- Founded
- OABI 2012
- CYBN 2019
- Country
- OABI United States
- CYBN Canada
- Employees
- OABI N/A
- CYBN N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- CYBN Pharmaceuticals and Biotechnology
- Sector
- OABI Health Care
- CYBN Health Care
- Exchange
- OABI Nasdaq
- CYBN Nasdaq
- Market Cap
- OABI 198.2M
- CYBN 174.9M
- IPO Year
- OABI N/A
- CYBN N/A
- Fundamental
- Price
- OABI $1.66
- CYBN $8.22
- Analyst Decision
- OABI Strong Buy
- CYBN Strong Buy
- Analyst Count
- OABI 3
- CYBN 4
- Target Price
- OABI $7.00
- CYBN $86.00
- AVG Volume (30 Days)
- OABI 1.1M
- CYBN 308.8K
- Earning Date
- OABI 08-07-2025
- CYBN 08-07-2025
- Dividend Yield
- OABI N/A
- CYBN N/A
- EPS Growth
- OABI N/A
- CYBN N/A
- EPS
- OABI N/A
- CYBN N/A
- Revenue
- OABI $26,744,000.00
- CYBN N/A
- Revenue This Year
- OABI N/A
- CYBN N/A
- Revenue Next Year
- OABI $45.65
- CYBN N/A
- P/E Ratio
- OABI N/A
- CYBN N/A
- Revenue Growth
- OABI 27.07
- CYBN N/A
- 52 Week Low
- OABI $1.22
- CYBN $4.81
- 52 Week High
- OABI $4.96
- CYBN $13.88
- Technical
- Relative Strength Index (RSI)
- OABI 53.98
- CYBN 54.45
- Support Level
- OABI $1.55
- CYBN $7.11
- Resistance Level
- OABI $1.73
- CYBN $8.19
- Average True Range (ATR)
- OABI 0.11
- CYBN 0.56
- MACD
- OABI 0.02
- CYBN -0.11
- Stochastic Oscillator
- OABI 68.13
- CYBN 53.11
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.